Eighteen patients with Guillain-Barre Syndrome (GBS) are on ventilators in Pune, India, in one of the largest outbreaks recorded. GBS, linked to Campy ...
The US Food and Drug Administration has approved Journavx, also known as suzetrigine 50 milligram oral tablets—a first-in-class non-opioid analgesic—to treat moderate to severe acute pain in adults.